nature neurOSCIenCe a r t I C l e S ALS is the most common form of motor neuron disease in the adult. Both sporadic and familial forms exist, and with the discovery of a GGGGCC (G4C2) intronic repeat expansion in the C9ORF72 gene, a common genetic cause of familial ALS has been identified 1,2 . The same intronic repeat expansion has also been discovered in patients with frontotemporal dementia (FTD) 2 , the second most common form of presenile dementia after Alzheimer's disease. ALS and FTD often co-occur in families and sometimes in the same patients (FTD-ALS), with similar clinicopathological features 1-4 . In healthy individuals, the number of repeats ranges from 2 to 23. In patients with ALS and FTD, sixty to several hundred G4C2 repeats are found in the C9ORF72 gene 4, 5 . The mechanism by which G4C2 repeat expansions cause neurodegenerative disease is still not clear. Three main hypotheses are discussed 6 . The first proposes that G4C2 repeat transcript as well as the antisense repeat transcript may accumulate in RNA foci that sequester RNA-binding proteins, leading to disturbed RNA metabolism, which causes neurodegeneration 7-9 . The second hypothesis builds on observations that the long repeat gives rise to proteins consisting of dipeptides by non-ATG translation (RAN translation) 10 . These dipeptide repeat proteins can then aggregate and cause neurodegeneration in affected brain regions 11 . The third hypothesis suggests that the expansion of repeats leads to haploinsufficiency of C9ORF72 expression, thereby resulting in loss of function 2 . Which of these different mechanisms predominates or whether they act together in the pathophysiology of ALS and FTD is unknown. In particular, little is known about the effects of loss of function of the protein encoded by C9ORF72 because its physiological function is still unclear.
a r t I C l e S ALS is the most common form of motor neuron disease in the adult. Both sporadic and familial forms exist, and with the discovery of a GGGGCC (G4C2) intronic repeat expansion in the C9ORF72 gene, a common genetic cause of familial ALS has been identified 1, 2 . The same intronic repeat expansion has also been discovered in patients with frontotemporal dementia (FTD) 2 , the second most common form of presenile dementia after Alzheimer's disease. ALS and FTD often co-occur in families and sometimes in the same patients (FTD-ALS), with similar clinicopathological features [1] [2] [3] [4] . In healthy individuals, the number of repeats ranges from 2 to 23. In patients with ALS and FTD, sixty to several hundred G4C2 repeats are found in the C9ORF72 gene 4, 5 . The mechanism by which G4C2 repeat expansions cause neurodegenerative disease is still not clear. Three main hypotheses are discussed 6 . The first proposes that G4C2 repeat transcript as well as the antisense repeat transcript may accumulate in RNA foci that sequester RNA-binding proteins, leading to disturbed RNA metabolism, which causes neurodegeneration [7] [8] [9] . The second hypothesis builds on observations that the long repeat gives rise to proteins consisting of dipeptides by non-ATG translation (RAN translation) 10 . These dipeptide repeat proteins can then aggregate and cause neurodegeneration in affected brain regions 11 . The third hypothesis suggests that the expansion of repeats leads to haploinsufficiency of C9ORF72 expression, thereby resulting in loss of function 2 . Which of these different mechanisms predominates or whether they act together in the pathophysiology of ALS and FTD is unknown. In particular, little is known about the effects of loss of function of the protein encoded by C9ORF72 because its physiological function is still unclear.
Loss of function is a possible pathomechanism, as patients with C9ORF72 repeat expansion show a 50% reduction in mRNA of both long and short transcripts 2, 3 . Recent studies revealed that reduction of C9ORF72 levels in both cortical and motor neurons does not affect cellular survival in vitro 10 or in vivo 12 . However, zebrafish models show reduced axon length in motor neurons and reduced locomotion after antisense morpholino-mediated reduction of C9ORF72 levels 5 . In contrast to the results in Caenorhabditis elegans and zebrafish, studies in mouse have so far not yielded conclusive results for C9ORF72 loss of function as a possible cause of FTD and ALS [13] [14] [15] [16] . Administering antisense oligonucleotides (ASOs) targeting mouse C9ORF72 by stereotactic intracerebroventricular injection reduced C9ORF72 mRNA levels to 30-40% of control levels in the spinal cord and brain 17 . C9ORF72 depletion in these mice is well tolerated and does not result in any behavioral or motor impairment. A mouse model with a conditional knockout allele for C9ORF72 has been generated using the Cre/loxP system. These mice were crossed to Nestin-Cre mice, which express Cre recombinase in neurons and glia starting at E10.5 and continuing into adulthood 18 . Cre-mediated inactivation of C9ORF72 in neurons and glia does not cause loss in motor neuron numbers or in motor function 19 , including motor performance and grip strength 14 . Hallmarks of ALS pathologies such as ubiquitinated TDP-43 aggregates and gliosis are not detected either. Thus, in two different mouse models, loss of C9ORF72 function is not sufficient to cause neurodegeneration and FTD-and ALS-related phenotypes.
However, these finding do not preclude the possibility that loss of C9ORF72 function contributes to neurodegeneration when combined with toxicity of dipeptides generated via RAN translation or dysregulated RNA metabolism. Loss of C9ORF72 in the mouse brain neuroblastoma cell line Neuro-2A cells has been shown to disturb the function of a complex involving WDR41 and SMCR8 that modulates GTPase function of Rab8a and Rab39b, leading to impaired autophagy in neurons 20 . To characterize the function of C9ORF72 in motor neurons, we investigated the interactome of C9ORF72 with quantitative proteomics and found that it immunoprecipitated with cofilin and other actin-binding proteins. Functional analyses in isolated mouse motor neurons and human induced pluripotent stem cells (iPSCs), as well as post-mortem analyses of patient brain tissues, revealed that C9ORF72 modulates actin dynamics via a pathway involving phosphorylation of cofilin through Arf6, Rac1 and LIMK1/2 activity. The resulting loss of actin dynamics could contribute to the capacity of neurons to maintain axons and axon terminals in the cellular pathology underlying ALS and FTD.
RESULTS

C9ORF72 modulates axon growth in cultured motor neurons
To understand the cellular function of C9ORF72, we used lentiviral vectors (Supplementary Fig. 1a,b) to overexpress or knock down C9ORF72 in primary mouse embryonic motor neurons. Immunostaining (Fig. 1a,b) , reverse transcriptase-PCR (Supplementary Fig. 1c) and immunoblots (Supplementary Fig.  1d ) showed that C9ORF72 levels were reduced ( Supplementary  Fig. 1c) or enhanced (Supplementary Fig. 1d,e) by about 50%, in primary mouse motor neurons cultured for 7 d. Overexpression or knockdown of the protein did not affect the survival of the cultured motor neurons (Supplementary Fig. 2a ). Compared to controls, axons were significantly longer in C9ORF72-overexpressing motor neurons at 7 d in culture and significantly shorter after knockdown ( Fig. 1c and Supplementary Fig. 2b,c) . Overexpression of human C9ORF72 rescued the effect of the knockdown, indicating that it is not due to off-target effects (Supplementary Fig. 2c ). C9ORF72 overexpression also led to increased growth cone size at day 5 in culture while knockdown reduced growth cone size compared to control (Fig. 1d) . These results indicate that C9ORF72 modulates axonal growth and growth cone size in spinal motor neurons.
C9ORF72 interacts with cofilin
To investigate the mechanism by which C9ORF72 acts on axon growth and differentiation, we determined interacting proteins by mass spectrometry (MS)-based proteomics. Because of the lack of suitable antibodies against mouse C9ORF72 protein, immunoprecipitation of endogenous protein was not possible. Therefore, we overexpressed influenza hemagglutinin (HA)-tagged human C9ORF72 protein and immunoprecipitated interacting proteins from mouse neuroblastoma NSC-34 cells (Supplementary Fig. 3a-c) . Interacting proteins were then analyzed by quantitative interaction proteomics as described 21, 22 . Key regulators of actin dynamics such as cofilin, a r t I C l e S Arp2/3 and coronin were among statistically significant interaction partners of C9ORF72 ( Fig. 2a and Supplementary Tables 1 and 2) . For further analysis, we first focused on cofilin, of which we identified two family members (Cfl1 and Cfl2) as significant C9ORF72 interactors. Cofilin is central to the regulation of actin dynamics and could therefore be responsible for reduced axon growth 23 and reduced size of axonal growth cones 24 . Immunoprecipitation of C9ORF72-HA from primary mouse motor neurons confirmed the interaction with cofilin by immunoblot analysis (Fig. 2b and Supplementary  Fig. 4a,b) . Endogenous cofilin pulldown revealed even stronger binding both of overexpressed C9ORF72-HA (Fig. 2c) and endogenous C9ORF72 (Fig. 2c) , probably because cofilin is more abundant in motor neurons and NSC-34 cells than the C9ORF72 protein 25 . This interaction was further confirmed by immunostaining in cultured mouse motor neurons, showing that C9ORF72-HA colocalized with cofilin in the cell body, axon shaft ( Fig. 2d ) and in particular in the axonal growth cone ( Fig. 2e and Supplementary Fig. 4c,d ).
C9ORF72 depletion enhances phosphorylation of cofilin
Cofilin is an ubiquitous actin-binding factor required for the reorganization of actin filaments. It promotes actin assembly or disassembly depending on its concentration relative to actin and relative to the concentration of other actin-binding proteins 26 . The activity of cofilin depends on phosphorylation at Ser3, which inactivates its function in F-actin assembly 27 . We found that overexpression of C9ORF72-HA protein reduced phosphorylation while knockdown increased cofilin phosphorylation (Fig. 3a) without any change in total cofilin levels ( Fig. 3a,b) . To test whether actin dynamics is also altered in human cells with C9ORF72 intronic expansion, we investigated immortalized lymphoblasts from three age-matched control and three C9ORF72 repeat expansion-carrier ALS (C9-ALS) patients. Immunoblots of lymphoblastoid cell extracts from these patients showed an upregulation of cofilin phosphorylation (Fig. 3c,d ). To study whether these cell culture experiments are representative of patients at disease stage, we investigated post-mortem brain tissue from three ALS patients with C9ORF72 intronic expansion and three age related controls. Using protein extracts from post-mortem cerebellum, we found reduced levels of endogenous C9ORF72 (P < 0.0001, unpaired Student's t-test) in the patient samples and a more than threefold upregulation of cofilin phosphorylation (P < 0.0001, unpaired Student's t-test) in the absence of altered cofilin levels (Fig. 3e,f) . The results from cultured mouse motor neurons, patient-derived lymphoblastoid cells and post-mortem brain tissue together demonstrate that cofilin phosphorylation is enhanced after depletion of C9ORF72 and under the genetic conditions of C9ORF72 intronic hexanucleotide expansion in patients.
Actin dynamics is disturbed in C9ORF72 depleted or mutated motor neurons We next tested whether C9ORF72 has an influence on actin dynamics by cloning a cDNA for cytoplasmic β-actin linked with GFP into a short hairpin RNA (shRNA) lentiviral vector for C9ORF72 repression (Supplementary Fig. 5a ). This allowed us to study actin dynamics by live cell imaging of cultured mouse motor neurons lacking C9ORF72. A scrambled sequence was used for the control GFP-actin construct. The expression of both constructs was confirmed by western blotting and immunostaining ( Supplementary Fig. 5b,c) , which showed . Phospho-cofilin levels were normalized to total cofilin and C9ORF72 levels were determined in relation to calnexin levels in extracts of lymphoblastoid cells from 3 healthy individuals and 3 ALS patients with repeat expansion in the C9ORF72 gene (3 independent experiments using independent extracts from the same cell lines). Unpaired Student's t-test, mean ± s.e.m., p-cofilin t = 13.07, df = 16, P < 0.0001; cofilin t = 1.935, df = 16, P = 0.0709; C9ORF72 t = 15.92, df = 16, P < 0.0001. a r t I C l e S colocalization of GFP-actin with phalloidin. We performed live cell imaging with mouse motor neurons at 5 d in culture because at this stage axon extension appears with highest speed and dynamics 28 ( Fig. 4a and Supplementary Videos 1 and 2) . The number of newly generated actin filaments was reduced in C9ORF72-depleted motor neurons (Fig. 4b) . C9ORF72 knockdown led to a significantly reduced velocity of actin movement in axonal growth cones compared to motor neurons transduced with scrambled control constructs (Fig. 4c,d ).
The dynamics of growth cone movement, as measured by the area into which the growth cone expanded over time, was also significantly reduced (Fig. 4e) . Thus actin dynamics is impaired when C9ORF72 levels are reduced in motor neurons. We then investigated actin dynamics in iPSC-derived human motor neurons from C9-ALS patients ( Supplementary Figs. 6 and 7) . Consistent with our observations in primary mouse motor neurons after C9ORF72 suppression, these induced human motor neurons showed reduced velocity of actin movement in axonal growth cones compared to healthy control individual-derived human motor neurons (Fig. 4f-i and Supplementary Videos 3 and 4). In parallel to the live cell imaging, we performed protein fractionation of F-actin and G-actin, which confirmed that G/F actin ratios were altered when C9ORF72 was knocked down or overexpressed in mouse motor neurons ( Fig. 5a-d ).
C9ORF72 depletion leads to activation of Arf6
The ability of cofilin to bind and depolymerize actin is abolished by phosphorylation of Ser3 (refs. 27,29 31 . Therefore, we tested whether cofilin phosphorylation is regulated by LIMK-1/2 phosphorylation by analyzing phospho-LIMK-1/2 levels after overexpression or knockdown of C9ORF72 in primary mouse motor neurons after 7 d in culture. Overexpression of C9ORF72-HA protein reduced LIMK-1/2 phosphorylation while knockdown increased LIMK-1/2 phosphorylation (Fig. 6a) , without any change in total LIMK protein levels. We then analyzed cofilin and LIMK phosphorylation in patient iPSC-derived motor neurons matured for 14 d (Fig. 6b) . A similar phenotype was observed to that in C9ORF72-depleted mouse motor neurons. These results indicate that C9ORF72 influences the phosphorylation of LIMK, which directly regulates the activity of cofilin. Recent publication have shown that C9ORF72 protein has homology to members of the Differentially Expressed in Normal and Neoplasia (DENN) protein family, which function as guanine nucleotide exchange factors (GEFs) or modulators of guanine nucleotide exchange factors to regulate Rab GTPase activity 32, 33 . Therefore, we searched for potential small GTPases among the proteins found in the C9ORF72 interactome and identified ADP-ribosylation factor-1 (Arf1) and Arf6 (Fig. 6c,d) . Arfs 34 constitute a family of Rasrelated, low molecular mass (~20 kDa) GTP-binding proteins that act as molecular switches for membrane and vesicle traffic, as well as actin dynamics in cells 35 . In a first step, the interaction of C9ORF72 with these small GTPases was confirmed by coprecipitation analyses, using antibodies against Arf6 (Fig. 6c) . This study was limited by the quality of available antibodies, and we therefore complemented it by experiments in which Flag-tagged Arf1 and Arf6 were overexpressed in NSC-34 cells (Fig. 6d) . Pulldown with Flag antibodies confirmed that C9ORF72 coprecipitates with Arf1 and Arf6 and thus might be present in the same complexes. a r t I C l e S Arf6 is essential for membrane trafficking and cytoskeletal rearrangement both in neuronal 36 and in non-neuronal cells 37 . We therefore analyzed the activity of Arf6 with gel shift assays to investigate whether C9ORF72 acts as a modulator of GTP/GDP binding to Arf6. The results show that C9ORF72 depletion in NSC-34 cells elevates the levels of GTP-bound Arf6 (Fig. 7a-c) , indicating that C9ORF72 does not act as a GEF for Arf6 but that it is involved in modulating this pathway. Rac1 acts as a downstream mediator of Arf6 activation 38 in a pathway that modulates actin dynamics. To study this pathway, we performed active GTPase immunoprecipitation assays in which the GTP-bound forms of Arf6 and Rac1 were pulled down. These data indicate that levels of the GTP-bound forms of these small GTPases are increased in the absence of C9ORF72 (Fig. 7d-f) , thus suggesting a mechanism by which actin dynamics is disturbed. The reduced level of C9ORF72 leads to more active, GTP-bound Arf6, which activates Rac1, thus leading to the phosphorylation of LIMK-1/2 and as a consequence to inactivation of cofilin by phosphorylation at Ser3. To test this hypothesis in more detail, we investigated whether knockdown of Arf6 could restore cofilin phosphorylation and altered axonal actin dynamics in motor neurons. Therefore, we investigated Rac1 activation in iPSC-derived motor neurons from C9-ALS patients. Under control conditions, enhanced Rac1 was observed, but knockdown of Arf6 by shRNA rescued this phenotype (Fig. 8a,b) . As a second line of evidence we investigated whether overexpression of constitutively dominant negative Arf6 (resembling Arf6-GDP) in parallel with knockdown of mouse C9ORF72 could rescue the axonal elongation a r t I C l e S phenotype. The results from (Fig. 8c,d ) demonstrate that the axonal elongation phenotype observed after knockdown of mouse C9ORF72 was rescued with overexpression of dominant negative Arf6. Together our data provide evidence that C9ORF72 regulates cellular actin dynamics via regulation of the GTPase activity of Arf6, cofilin phosphorylation and possibly other proteins shaping the actin cytoskeleton. Our data also explain the axonal phenotype observed in zebrafish after C9ORF72 suppression 5 . Thus, loss of function of C9ORF72 could contribute to the clinical phenotype in ALS and FTD because reduced actin dynamics influences synaptic strength 39 , maintenance 40 and axon stability 40 .
DISCUSSION
Several previous studies have shown that cells derived from C9ORF72 patients have decreased levels of C9ORF72 transcripts 5 , raising questions on the cellular function of C9ORF72 and whether loss of this function could contribute to the pathophysiology of ALS and FTD 6, 41 . C9ORF72 has been implicated in intracellular membrane trafficking 32, 33 . Our liquid chromatography (LC)-MS and immunoprecipitation analyses revealed that C9ORF72 is in a complex with key regulators of actin dynamics such as cofilin, Arp2, Arp3 and coronin.
Cofilin is an ubiquitous actin-binding factor required for the organization of actin filaments 26 . The activity of cofilin depends on phosphorylation at Ser3, which inactivates its function in F-actin assembly 27, 29 . Recent studies have shown that cofilin is essential for actin bundling in axons and that augmented retrograde flow of actin filaments appears to be an essential component of axon elongation 23 . The same study showed that cofilin knockout results in impaired axon growth, similar to that in C9ORF72-depleted mouse motor neurons observed in our study. This emphasizes the importance of cofilin activity for axonal maintenance in motor neurons. The activity of cofilin is regulated by phosphorylation through LIMK-1/2. These serine/ threonine kinases are activated by effector kinases of small GTPases, in particular PAK1 and PAK4 (ref. 42 ). These effector kinases act downstream of Rac1, which itself is activated by Arf6 (refs. 38, 43) and Arf1 (ref. 44) . The observation that the GTP-bound forms of Rac1 and Arf6 are increased when C9ORF72 is repressed in primary mouse motor neurons or in patient iPSC-derived motor neurons strongly suggests that C9ORF72 is essential for the GTP exchange activity of Arf6 in particular. This conclusion is supported by the observation that knockdown of Arf6 expression in iPSC-derived motor neurons normalizes the enhanced levels of GTP bound Rac1. Expression of a dominant negative Arf6 (ref. 36) or depletion of Arf6 (ref. 45) enhances axon elongation, which fully supports our observations that enhanced activity of Arf6 in C9ORF72-deficient neurons correlated with reduced axon growth and that expression of a dominant negative Arf6 in C9ORF72-depleted motor neurons or in iPSC-derived motor neurons from C9-ALS patients rescued the axonal defects observed after C9ORF72 depletion.
Bioinformatic analysis has revealed that C9ORF72 contains a DENN domain, which is characteristic of the family of DENN proteins, some of them showing activity as GDP/GTP exchange factors for Rab GTPases and possibly also other small GTPases 32, 33 . This appears in line with the observation that C9ORF72 colocalizes with Rab1, Rab5, Rab7 and Rab11 and that depletion of C9ORF72 inhibits endocytosis and vesicle trafficking in neuronal cell lines 46 . A recent study identified C9ORF72 protein in Neuro-2A cells as component of a complex with SMCR8 and WDR3 exhibiting GEF activity for Rab8a and Rab39 (ref. 20) . In our mass spectrometric analysis, we did not observe a specific interaction of C9ORF72 with SMCR8 and WDR41. This may be because the proteomes of Neuro-2A cells and primary motor neurons differ 25 , in particular with respect to proteins relevant for cytoskeletal organization and presynaptic differentiation. This previous study also did not find evidence that the C9ORF72 protein itself acts as a GEF for these Rab proteins. SMCR8 bound to Rab8 and Rab39 independently of C9ORF72, indicating that C9ORF72 itself does not function as a GEF in this context but rather as a modulator of the GEF activity of SMCR8. Thus, the question remains open whether small GTPases are modulated directly by C9ORF72 and how C9ORF72 achieves this function as a modulator of GDP/GTP binding 32, 33 . In our study, we identified enhanced GTP binding in Arf6 and Rac1 after C9ORF72 depletion. This effect was also observed in iPSC-derived motor neurons from C9-ALS patients and in lymphoblastoid cells and post-mortem brain samples from C9-ALS patients. We do not know yet how C9ORF72 modulates the GTP binding of these small GTPases. It could be via action as a GEF for one or more upstream small GTPases or via inhibition of other GEFs for Arf6 and Rac1, which then results in LIMK-1/2 phosphorylation of cofilin. Such potential allosteric mechanisms that modulate GEF activity have been identified in the context of differential regulation of Ras and Rac activity by Sos. When Sos is bound to Abi1 (also called E3B1), Eps8 and PI3K 47 , it acts as a GEF for Rac. However, when Sos is bound to Abi1, it cannot bind to Grb3, and thus its GEF activity for Ras is reduced 48 . Such a mechanism could explain the enhanced GTP binding of Arf6 and Rac1 when C9ORF72 levels are low in iPSCderived motor neurons from C9-ALS patients, in post-mortem brain samples from C9-ALS patients and in primary mouse motor neurons after lentiviral C9ORF72 knockdown.
The presence of cofilin, coronin and other actin modulatory proteins in complexes with endogenous C9ORF72 indicates that the modulation of actin dynamics could constitute an essential cellular function of C9ORF72 in motor neurons. Enhanced phosphorylation of LIMK-1/2 and cofilin in iPSC-derived neurons and in post-mortem brain samples of C9-ALS patients indicates that this mechanism might contribute to the pathology in ALS and FTD.
METhODS
Methods, including statements of data availability and any associated accession codes and references, are available in the online version of the paper. Isolation and culture of primary embryonic mouse motor neurons. Spinal cords from E13.5 mouse CD1 embryos were isolated and motor neurons were prepared as described previously 49 using a p75NTR antibody for panning 50 . For axon length measurement, motor neurons were plated at a density of 2,000 cells/cm 2 . For live imaging, 10,000 cells per 3.5 cm 2 and for immunoprecipitation 1,000,000 cells per 6.4 cm 2 dish were used. Lentiviral knockdown or overexpression virus was prepared as described previously 51 . Experiments were performed by incubation of motor neurons directly before plating with either viruses for overexpression, control scrambled construct or knockdown viruses, respectively, for 8 min at room temperature. Infected cells were identified by staining and western blotting. overexpression and knockdown shRnA in cultured mouse and human motor neurons. To knock down C9ORF72 in cultured mouse motor neurons, we chose the target sequence 5′-GGTCCTAGAGTAAGGCATATT-3′ for C9ORF72 and cloned it into the pSIH-H1 shRNA vector (System Bioscience): C9ORF72 shRNA top-oligo (5′-gatccGGTCCTAGAGTAAGGCATATTtcaagag AATATGCCTTACTCTAGGACCTTtttg-3′), control scrambled-oligo (5′-gatccGG GAATTATAACGGCTTGACTtcaagagAGTCAAGCCGTTATAATTCCC TTtttg-3′). The construct for overexpressing C9ORF72 was created using PCR primers specific for human C9ORF72 from human cDNA. The human C9ORF72 cDNA was cloned into a FuVal Vector system driven by an ubiquitin promoter. For knockdown of human Arf6 we chose the target sequence 5′-GCACCGCATTATCAATGACCG-3′ and cloned it into pSIH-H1 shRNA vector. Arf6 shRNA top-oligo (5′-gatccGCACCGCATTATCAATGACCGCTT CCTGTCAGACGGTCATTGATAATGCGGTGCttttt-3′, control scrambled oligo (5′-gatccGCAAACACGCGCTCTCTTGAACTTCCTGTCAGATTCAAGAG AGCGCGTGTTTGCttttt-3′). To rescue the axonal length phenotype observed after knockdown of mouse C9ORF72 we cloned the Arf6 DN T27N construct (Addgene plasmid number 10831) into the GFP coding region of the pSIH-H1 shRNA vector (System Bioscience) containing scrambled or C9ORF72 shRNA. The lentivirus produced from the vector was always titered and equal virus/cell ratio was used in all experiments. Cultures of mouse motor neurons were infected in suspension before plating and harvested after 5 or 7 DIV. Cells were analyzed by western blot or immunostaining.
Protein isolation, immunoprecipitation and western blotting. Plated primary cultured mouse motor neurons or mouse neuroblastoma NSC-34 cells were obtained from Biozol, Eching, Germany (order number CED-CLU140). The identity of the cell line was confirmed by the supplier. Cells were regularly tested for mycoplasma contamination using Venor GeM Mycoplasma Detection Kit (catalog number: MP0025, Sigma-Aldrich). The cells were washed twice with icecold phosphate-buffered saline (PBS) and directly lysed for immunoprecipitation in immunoprecipitation buffer (25 mM Tris-HCl pH 7.5, 150 mM NaCl, 2 mM EDTA, 2 mM EGTA, 10% glycerol (vol/vol), 0.1% NP-40 (vol/vol), 2 mM Na 3 VO 4 , 50 mM NaF) with protease and phosphatase inhibitors. The lysates were scraped off and collected in a 1.5-ml centrifuge tube and centrifuged at 10,000g for 5 min. The supernatant was collected and preincubated with Protein-G-agarose (Roche) for 1 h at 4 °C. Protein pulldown was performed using 1-4 µg primary antibody (antibody to HA, cofilin or C9ORF72) after incubation at 4 °C for 6 h, followed by incubation with Protein-G-agarose (Roche) for 1 h at 4 °C. Sedimented complexes were washed three times with immunoprecipitation buffer and one time with PBS and resuspended in SDS-PAGE loading buffer. For complete cell lysis, primary cultured mouse motor neurons, human lymphoblastoid cells, human post-mortem tissues and human iPSC-derived motor neurons were lysed in RIPA buffer (50 mM Tris pH 8.0, 1% NP40, 0.5% sodium deoxycholate, 0.1% SDS, 150 mM NaCl, 2 mM EDTA, 50 mM NaF) with protease and phosphatase inhibitors. The protein lysate was quantified with BCA (Pierce BCA Protein Assay Kit). Samples were subjected to SDS PAGE and immunoblotted 52 .
characteristics of donors of brain autopsy material. Post-mortem brain was obtained and isolated from three patients with ALS und three control individuals without neurological disorders. All had given informed consent. All procedures were in accordance with the Helsinki convention and approved by the Ethical Committee of the University of Sheffield. Three ALS patients showed intronic expansion of the C9orf72 locus (63/08, 160/96, 39/11); ages at death were 69, 62 and 72 years; two females and one male. Duration of disease was 26, 26 and 14 months. Control subjects (005/07, 85/07, 010/96) did not have neurological disorders; ages were 63, 63 and 59; one patient died of pneumonia; one male and two females.
Analysis of human samples. Lymphoblastoid cells from three C9ORF72-ALS patients with more than 63 repeats (female 58 years, male 64 years, male 57 years) and three neurologically normal population controls (male 72 years, female 59 years, female 71 years) were obtained from the Department of Neurology, University of Wuerzburg, Germany. The presence or absence of intronic C9ORF72 hexanucleotide expansion was determined by repeat-primed PCR analysis of DNA. Lymphoblastoid cells cultured for a maximum of three passages were used for western blot analysis. Human post-mortem brain samples from cerebellum of ALS patients with C9ORF72 intronic expansions were obtained from Sheffield Brain Tissue Bank, Sheffield Institute for Translational Neuroscience. Tissues were kept frozen at −80 °C before use, and each tissue block was cut in four independent pieces that were separately processed and analyzed by western blot analysis.
Sample preparation for lc-mS analysis using nSc-34 cells. NSC-34 cells were cultured in Dulbecco's MEM (DMEM, Gibco) supplemented with 10% FBS and 1% penicillin/streptomycin under standard culture conditions. Control cells and cells for overexpressing HA-hC9ORF72 were split and seeded at equal density on a six-well dish. The cells were maintained in the same medium without penicillin/ streptomycin and transfected with the overexpression plasmid the next day. The cells were collected at day 4 after transfection and processed for immunoprecipitation as described above. The supernatant was collected and preincubated with Sepharose 6 Fast Flow (GE, 17-0969-01) for 1 h at 4 °C. Protein pulldown was performed using 30 µl HA antibody-coupled beads (Covance, AFC-101P-1000) at 4 °C for 6 h. The sedimented complex was washed three times with lysis buffer and three times with PBS and stored at −80 °C. For proteolytic digestion, the samples were resuspended in 8 M urea (20 mM HEPES, pH 8). Proteins were reduced with 10 mM DTT for 30 min followed by alkylation of cysteines with 55 mM iodoacetamide for 45 min. We added 1 µg of LysC and digestion of proteins was carried out for 3 h at room temperature. The urea was diluted by a factor of five with 50 mM ammonium bicarbonate and the mixture was digested overnight with 1 µg trypsin.
lc-mS data acquisition and analysis. Samples were desalted via C18 StageTips 53 . We used liquid chromatography (Thermo Scientific EASY-nLC 1000 HPLC) with columns packed in-house (75 µm inner diameter, 20 cm length, 1.9 µm C18 particles (Dr. Maisch GmbH, Germany). Peptides were separated at 50 °C in a 102-min gradient from 98% buffer A (0.5% formic acid) and 5% buffer B (0.5% formic acid to 80% acetonitrile) to 60% buffer B at 250 nl/min. The LC was directly coupled to an Orbitrap mass spectrometer (Orbitrap Elite 54 , Thermo Fisher Scientific) via a nanoelectrospray source. The mass spectrometer was operated in a datadependent acquisition mode. Following a survey scan (MS1, 300 to 1.650 m/z) at a resolution of 120,000 up to the 10 most abundant isotope patterns (charge ≥ 2) were subjected to collision-induced dissociation (isolation window of 2 Th, normalized collision energy of 35). Isotope patterns that had been subjected to fragmentation were excluded for the subsequent cycles (30 s) to reduce resequencing. Xcalibur software (Thermo Scientific) was used to record the data. data analysis. We processed MS raw data searching against the UniProtKB mouse FASTA database (06/2012) with MaxQuant software 55 (v 1.3.8.2 ) and the Andromeda search engine 56 using standard settings. Carbamidomethylation of cysteine residues was set as a fixed modification. We set enzyme specificity to trypsin, allowing cleavage N-terminal to proline and up to two miscleavages, with a 1% false discovery rate (FDR) cut-off on the level of peptides and proteins. After nonlinear retention time calibration, identifications were matched to unidentified MS 1 features across the samples within a 0.5-min time window (MaxQuant 'matching between runs' algorithms). For quantification we used MaxLFQ label-free algorithms 57 . Before statistical analysis we strictly excluded potential contaminants (n = 247) and proteins only identified with site modifications. Statistical analysis was performed in PERSEUS 58 and R 59 . Data were filtered for at least two valid values in at least one condition and remaining missing values were imputed with a normal distribution based on the whole data set (width = 0.3; shift = 1.8). We determined significant outlier with t-test statistics (permutation-based false discovery rate of 5% and S0 of 0.1). To assess the interactome on cellular pathway level we performed a 1D annotation enrichment on the t-test difference. For the enrichment analysis we applied a Benjamini-Hochberg FDR at 2% (Fig. 2a and Supplementary Tables 1 and 2 ). g-actin F-actin separation and determination of the g/F ratio. The cultured mouse motor neurons used for G/F actin ratio quantification were collected after 7 d infection with lentivirus. They were washed three times in 37 °C PBS (PAA Laboratories, pH 7.4) before lysis with actin stabilization buffer (0.1 M PIPES pH 6.9, 30% glycerol (vol/vol), 5% DMSO (vol/vol),1 mM MgSO4, 1 mM EGTA, 1% Triton X-100 (vol/vol), 1 mM ATP, complete protease inhibitor and phosphatase inhibitor. The lysis was kept at 37 °C for 10 min. Cells were dislodged by scraping and the entire extract centrifuged at 37 °C for 75 min in an ultracentrifuge (Beckmann, rotor TLA-120.1) at 100,000g. The supernatant containing G-actin was recovered and the pellet containing F-actin collected separately and resuspended with RIPA buffer. The total protein concentration was quantified by BCA (Pierce BCA Protein Assay Kit) and equal protein concentrations were used for western blotting.
Immunocytochemical analysis of embryonic mouse motor neurons. Cells were washed with warm PBS (PAA Laboratories, pH 7.4) to remove serum and debris, and fixed with 4% paraformaldehyde for 15 min at room temperature. Permeabilization and blocking of cell was done in PBS with 0.1% Triton X-100, 0.3% Tween-20, 10% donkey serum or goat serum and 5% BSA for 20 min. Primary antibodies were applied overnight at 4 °C. Cells were washed thoroughly and incubated with appropriate fluorescent secondary antibodies for 1 h at room temperature. Cells were washed three times with PBS and subsequently incubated with fluorescent phalloidin (100 nM for PHDH1 and 200 nM for PHDN1, Cytoskeleton) for 1 h at room temperature. The cells were washed once with PBS and nuclei were counterstained with the dye 4′,6′-diamidine-2′-phenylindole, dihydrochloride (DAPI, Sigma, at a final concentration of 5 µg ml −1 ). Coverslips were embedded with Mowiol (SigmaAldrich, 10852) and imaged subsequently.
The following secondary antibodies were used for immunohistochemistry in this study: donkey anti-rat IgG (H+L) IgG (Alexa Fluor 488, Jackson, 712-545-150, 1:800), donkey-anti-rabbit IgG Affi-pure (H+L) IgG (Alexa Fluor 488, Jackson, 711-545-152), donkey-anti-rabbit IgG Affi-pure (H+L) IgG (Cy3, Jackson, 711-165-152, 1:800), donkey-anti-mouse IgG Affi-pure (H+L) IgG (Cy3 Jackson, 715-505-150, 1:800) and phalloidin cross-linked with a 555 nm fluorochrome (Cytoskeleton, PHDH1,100 nM) or 670 nm fluorochrome (Cytoskeleton, PHDN1, 200 nM) was used for labeling F-actin. confocal microscopy. Digital confocal images were acquired using an Olympus FluoView TM FV1000 microscope equipped with the Olympus FluoView1000 viewer software. Linear contrast and brightness enhancement was similarly applied within corresponding picture groups using ImageJ. Pictures were arranged with and labeled with Adobe Illustrator.
Patient characteristics for donors of iPSc lines. We included cell lines from two different C9ORF72 ALS patients: line 1, ALSbi (behavioral impairment), bulbar onset, female, age at onset 66, age at biopsy 68, disease duration 2 years, father also bulbar onset rapid progressive ALS; line 2, ALS-FTD (frontotemporal dementia), bulbar onset, female, age at biopsy 51, father died by generalized weakness and respiratory failure. We systematically compared those to control iPSCs from healthy volunteers 60, 61 (female, age at biopsy 48; female, age at biopsy 45). All procedures were in accordance with the Helsinki convention and approved by the Ethical Committee of the Technische Universität Dresden (EK45022009; EK393122012). generation and expansion of iPScs, in vitro differentiation of embryoid bodies. For generating iPSC lines fibroblasts were established from skin biopsies taken from familial ALS patients. The generation and characterization of control iPSC line has been reported previously [60] [61] [62] . Human iPS cells were regularly tested for mycoplasma contamination using the Mycoplasma Detection Kit for Conventional PCR No 11-1025 (Venor GeM, Berlin, Germany). Embryoid body formation was done as described previously 60, 62, 63 .
iPSC colonies were stained with markers for pluripotency as described 62 . In addition, differentiated embryoid bodies were stained with rabbit anti-α-SMA (1:500, Sigma-Aldrich), mouse anti-FN (1:400, Sigma), mouse anti-TUJ1 (1:1,000, Covance) and mouse anti-β-catenin (BD Bioscience 1:500) and Alexa Fluor secondary antibodies (Invitrogen Molecular Probes, cat. nos. A21202, A31570 or A31571, 1:500) and counterstained with Hoechst.
karyotyping. C9ORF72 iPSC lines were karyotyped using the HumanCytoSNP12v array. All clones showing pathological SNPs were excluded (data not shown) as described previously 60 .
genotyping. C9ORF72 iPSCs were genotyped after all other characterization had been finished. This was done by a diagnostic human genetic laboratory (CEGAT, Tübingen, Germany) using clinical diagnostic standards. Only lines carrying >50 hexanucleotide repeats were included.
derivation of neural progenitor lines and differentiation of motor neurons.
Neural progenitor lines were derived as previously described 64 . Motor neurons were differentiated by changing the NPC expansion medium to N2B27 with 1 µM PMA 3 d after splitting. Two days later, 1 µM retinoic acid (Sigma) and 1 µM PMA were added for 8 d more. Following 1 d in maturation medium (N2B27 with BDNF, GDNF, and dbcAMP), cultures were also split as clumps at a ratio of 1:2 to 1:3. Cells were cultured in maturation medium for 14 d in culture.
live cell imaging of actin dynamics. A GFP-tagged cytoplasmic actin construct was prepared using plasmids carrying the β-actin cDNA under the control of a CMV promoter as described 65 . The GFP coding region of the pSIH-H1 shRNA vector (System Bioscience) containing scrambled or C9ORF72 shRNA was fused in-frame to the actin coding cDNA to obtain a construct encoding β-actin with a N-terminally fused GFP followed by a 11 amino acid linker sequence. Actin dynamics was analyzed in transduced cultured motor neurons at 5 DIV with GFP-actin scrambled shRNA or GFP-actin C9ORF72 shRNA seeded in a 35-mm high µ-Dish at a density of 10,000 cell plated on laminin 221. The motor neurons used for live cell imaging were washed three times with 37 °C Neurobasal medium (phenol red free) and then incubated with fresh Neurobasal medium (phenol red free) with BDNF (5 ng/ml) for 30 min at 37 °C at 5% CO 2 . Live cell imaging for the human iPSC-derived motor neurons was done on 7-d-old matured neurons. The control and C9ORF72 ALS patient-derived spinal motor neurons were seeded in a 35-mm, high µ-Dish at a density of 15,000 cells plated on laminin 221 for maturation. The cells were infected with GFP-actin scrambled shRNA on DIV 4 and the live cell imaging performed on DIV 7. Before imaging, the cells were washed three times with 37 °C Neurobasal medium (phenol red free) and then
